CCL.NS(CCL.NS)
CCL.NS
No analyst ratings available
No analyst price targets available for CCL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $49.05B | $56.81B | $65.29B | $70.62B |
| Low | $46.04B | $53.53B | $61.41B | $66.43B |
| High | $51.72B | $59.75B | $68.75B | $74.36B |
| EBITDA Avg | $9.18B | $10.63B | $12.22B | $13.22B |
| Low | $8.62B | $10.02B | $11.50B | $12.43B |
| High | $9.68B | $11.18B | $12.87B | $13.92B |
| EBIT Avg | $7.49B | $8.67B | $9.97B | $10.78B |
| Low | $7.03B | $8.17B | $9.38B | $10.14B |
| High | $7.90B | $9.12B | $10.49B | $11.35B |
| Net Income Avg | $5.05B | $6.30B | $7.56B | $9.22B |
| Low | $4.81B | $5.70B | $6.98B | $8.50B |
| High | $5.28B | $6.78B | $8.08B | $9.85B |
| EPS Avg | $37.89 | $47.23 | $56.68 | $69.10 |
| Low | $36.10 | $42.77 | $52.30 | $63.76 |
| High | $39.61 | $50.83 | $60.58 | $73.85 |
| Analysts (Rev / EPS) | 12 / 12 | 11 / 11 | 5 / 4 | 6 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $12.25B | $11.85B | $11.94B |
| Low | $12.25B | $11.85B | $11.94B |
| High | $12.25B | $11.85B | $11.94B |
| EBITDA Avg | $2.29B | $2.22B | $2.24B |
| Low | $2.29B | $2.22B | $2.24B |
| High | $2.29B | $2.22B | $2.24B |
| EBIT Avg | $1.87B | $1.81B | $1.82B |
| Low | $1.87B | $1.81B | $1.82B |
| High | $1.87B | $1.81B | $1.82B |
| Net Income Avg | $1.31B | $1.33B | $1.37B |
| Low | $1.31B | $1.33B | $1.37B |
| High | $1.31B | $1.33B | $1.37B |
| EPS Avg | $9.85 | $10.00 | $10.25 |
| Low | $9.85 | $10.00 | $10.25 |
| High | $9.85 | $10.00 | $10.25 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |